SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-15-000133
Filing Date
2015-02-06
Accepted
2015-02-06 16:27:38
Documents
1
Group Members
ABINGWORTH BIOVENTURES VI, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G paratek13gdec312014.htm SC 13G 74291
  Complete submission text file 0000905718-15-000133.txt   75992
Mailing Address 75 KNEELAND STREET 6TH FLOOR BOSTON MA 02111
Business Address 75 KNEELAND STREET 6TH FLOOR BOSTON MA 02111 (617) 275-0040
Paratek Pharmaceuticals, Inc. (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81821 | Film No.: 15584915
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

IRS No.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13G